GlaxoSmithKline Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26
GlaxoSmithKline Pharmaceuticals Ltd · Outcome · 04 Nov 2026, 12:19 am
GlaxoSmithKline Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 1,18,357 (+20.8% YoY | +26.1% QoQ) ■ EBITDA: 40,207 (+19.8% YoY | +36.1% QoQ) ■ EBITDA Margin (%): 34.0 (-29 bps YoY | +248 bps QoQ) ■ PAT: 33,588 (+30.4% YoY | +41.6% QoQ) ■ EPS (INR): 19.8 (+31.6% YoY | +41.6% QoQ)
Original exchange filing (PDF)
More announcements from GlaxoSmithKline Pharmaceuticals Ltd
- As per attachment · 08 Nov 2026
- As per attachment · 05 Nov 2026
- As per attachment · 05 Nov 2026
- Analyst meet Presentation · 04 Nov 2026
- As per attachment · 04 Nov 2026
- As per attachment · 04 Nov 2026
- As per attachment · 04 Nov 2026
- outcome of Meeting · 04 Nov 2026
